Following the emergence of new COVID-19 variants, including Omicron, a team from Oregon State University recently published new research in academic journals. Their findings suggest that two components found in hemp, cannabigerolic acid (CBGA) and cannabidiolic acid (CBDA), can prevent the coronavirus from entering human cells, potentially leading to new ways to prevent and treat COVID-19.
The research, titled “Cannabinoids Block Cellular Entry of SARS-CoV-2 and the Emerging Variants,” found that both CBGA and CBDA can block the activity of the COVID-19 virus and shorten the duration of infection. The hemp components are equally effective against mutant virus species, including the Alpha and Beta variants.
Lead researcher Reman explained that the safety record of the two single-dose cannabinoid acid groups for use in humans is well established, making them a viable option for preventing SARS-CoV-2 infection. The acids wrap around the coronavirus’ spiny protein, preventing the virus from entering human cells.
Van Breeman, another researcher on the team, noted that hemp acid could be used to prevent coronavirus infection by blocking cellular entry. Additionally, the components can shorten the duration of infection by preventing viral particles from infecting body cells.
Further research is necessary to understand the effects of cannabinoid acid on other virus species. However, the researchers suggest that cannabinoid acid could be produced as a preventative drug. They hope to conduct further studies in the future, covering other virus species that are currently spreading or may arise in the future.
Those who interested in ordering high-quality hemp products or seeking more information contact us through:
Facebook inbox : KannabizTech
Line@ : @Kannabiz.Tech
E-Mail : Sale@Kannabiztech.co.th
Tel. : 02-026-6909